Genome sequencing recommended as first-line test

The American Academy of Pediatrics (AAP) now recommends whole genome sequencing (WGS) as a first-line test for children with global developmental delay and intellectual disability (GDD/ID) when no clear diagnosis is suspected.

Benefits of Whole Genome Sequencing

A digital graphic with purple rounded rectangles, each containing white checkmarks and white text. The points discuss benefits related to medical diagnosis and care strategies for rare diseases, including shortening diagnostic odysseys, providing personalized care, helping families plan, and potentially expanding Medicaid support.

How Jura Health Helps:

Jura Health delivers an ultra-comprehensive solution for each patient that is clear, actionable, personalized, and designed to remain relevant over time. Every test includes: